Effect of drug concentration on adsorption of levofloxacin by polyacrylonitrile haemofilters

International Journal of Antimicrobial Agents

Volumn 28, Issue 2, 2006, Pages 147-150

  Tian, Qi ^a   Gomersall, Charles D ^a   Wong, April ^a   Leung, Patricia ^a   Choi, Gordon ^a   Joynt, Gavin M ^a   Tan, Perpetua ^a   Lipman, Jeff ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Adsorption; Kidney failure; Pharmacokinetics; Quinolones; Renal replacement therapy

Indexed keywords

LEVOFLOXACIN; POLYACRYLONITRILE; QUINOLONE DERIVATIVE; RINGER LACTATE SOLUTION;

ANIMAL CELL; ARTICLE; BLOOD PUMP; DRUG ADSORPTION; DRUG EFFECT; FILTER; HEMOFILTRATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FAILURE; NONHUMAN; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; ULTRAFILTRATION;

ACRYLIC RESINS; ADSORPTION; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMOFILTRATION; HUMANS; KIDNEY FAILURE; MODELS, BIOLOGICAL; OFLOXACIN;

EID: 33746301921     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.03.025     Document Type: Article

References (10)

1. Rahman T.M., and Treacher D. Management of acute renal failure on the intensive care unit. Clin Med 2 (2002) 108-113
2. Klenzak J., and Himmelfarb J. Sepsis and the kidney. Crit Care Clin 21 (2005) 211-222
3. Bugge J.F. Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients. Acta Anaesthesiol Scand 45 (2001) 929-934
4. Hansen E., Bucher M., Jakob W., Lemberger P., and Kees F. Pharmacokinetics of levofloxacin during continuous veno-venous hemofiltration. Intensive Care Med 27 (2001) 371-375
5. Böhler J., Donauer J., and Keller F. Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage. Kidney Int 56 Suppl. 72 (1999) S24-S28
6. Choi G., Gomersall C.D., Lipman J., et al. The effect of adsorption, filter material and point of dilution on antibiotic elimination by haemofiltration. An in vitro study of levofloxacin. Int J Antimicrob Agents 24 (2004) 468-472
7. Böttcher S., von Baum H., Hoppe-Tichy T., Benz C., and Sonntag H.G. An HPLC assay and a microbiological assay to determine levofloxacin in soft tissue, bone, bile and serum. J Pharm Biomed Anal 25 (2001) 197-203
8. Yap F.H., Joynt G.M., Buckley T.A., and Wong E.L. Association of serum albumin concentration and mortality risk in critically ill patients. Anaesth Intensive Care 30 (2002) 202-207
9. Bellmann R., Egger P., Gritsch W., et al. Elimination of levofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration. Int J Clin Pharmacol Ther 40 (2002) 142-149
10. Malone R.S., Fish D.N., Abraham E., and Teitelbaum I. Pharmacokinetics of levofloxacin and ciprofloxacin during continuous renal replacement therapy in critically ill patients. Antimicrob Agents Chemother 45 (2001) 2949-2954